THE PRECISION / OPTIUM POINT OF CARE BLOOD GLUCOSE TEST STRIPS— 510(k) K070984

Substantially Equivalent

Abbott Diabetes Care, Inc.

FDA 510(k) clearance K070984 for THE PRECISION / OPTIUM POINT OF CARE BLOOD GLUCOSE TEST STRIPS, Substantially Equivalent on 2007-11-01. Applicant: Abbott Diabetes Care, Inc..

Clearance details

Applicant
Abbott Diabetes Care, Inc.
Product code
Code LFR
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Alameda, CA, US
Download summary PDFView on FDA.gov ↗

Adverse events under product code LFR

product code LFR
Death
3
Malfunction
1,634
Total
1,637

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.